A triple-digit jump in diabetes members has driven Livongo Health to third quarter results that beat sales and profit expectations. The digital heath player posted third quarter sales of $46.7 million ...

This high-flying healthcare stock still has tremendous growth opportunities ahead. Livongo Health's story is similar to that of many successful companies. It saw a need and developed a solution to ...

A day after Livongo’s president spoke in detail about the data partnership the company struck with Dexcom, a top continuous glucose monitoring company, its stock edged up — to nearly $31. Since the ...

Sumi Das, a partner at CapitalG, has high hopes for the next generation of Livongos. Livongo, a tech-forward chronic care company, is often given credit for paving the way for digital health startups.

Livongo shares have skyrocketed -- but so has revenue growth. Livongo uses technology to help its members monitor and manage their chronic conditions such as diabetes and hypertension. Using ...

Mountain View, California-based Livongo Health, the chronic condition management technology company founded by former Allscripts CEO Glen Tullman, has acquired Diabeto, a diabetes management company ...

In partnership with Horizon Blue Cross Blue Shield of New Jersey and the State of New Jersey, Livongo for Diabetes is now available to over 460,000 people; bringing digital health to the forefront of ...

San Diego’s Dexcom has inked a deal with Livongo Health’s digital platform to better help people with diabetes manage the disease. The partnership enables Dexcom customers to sync readings from ...

Livongo is a recent digital health IPO with a SAAS-style business model that leverages AI to help people manage their chronic conditions. With revenue growth of 148% and gross margins of 75% in Q3 ...

Like most stocks, Livongo Health (NASDAQ: LVGO) plunged during the stock market meltdown in March. But Livongo's rebound has been more spectacular than most. Its shares are now up more than 100% year ...